Clinical Trial Update: Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating various doses of Ro 27-2771 in asthma patients not treated with inhaled corticosteroids. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Ro 27-2771

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 2 | Status: COMPLETED